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Abstract This study aimed to gain insight into the gate-
keeper role of surgeons and gastroenterologists (including
residents) during a first consultation at a tertiary gastro-
intestinal centre regarding referral for genetic counselling,
and to test the feasibility of a checklist for indications for
referral. Consecutive patients were invited before and after
introduction of a checklist, to complete a questionnaire
assessing their perception of discussing cancer genetic
topics. Initial consultations were audiotaped to assess the
quality of this discussion by gastroenterologists and sur-
geons. Data on completeness of the checklist and referral
were collected from medical files. No significant differ-
ences were found between the Before and After group
regarding patients’ reports of discussing cancer in the
family (77 %, n = 34 vs 89 %, n = 33, p = 0.16). In
28 % (n = 10) of the audiotaped consultations family
history was adequately discussed, in 58 % (n = 21) it was
considered inadequate and in 14 % (n = 5) of consulta-
tions it was not discussed at all. A checklist was present in
53 % (n = 27) of the medical files. Of these, 5 (19 %)
were incomplete. Gastroenterologists and surgeons (in
training) have difficulty in fulfilling their gatekeeper role of
recognizing patients at familial risk for CRC. Although
they often discuss familial cancer during the initial
consultation, their exploration seems insufficient to reveal
indications for referral for genetic counselling. Therefore,
healthcare professionals should not only understand
genetics and the importance of cancer family history, but
also be effective in the communication of this subject to
enable more adequate referral of patients for genetic
counselling.
Keywords Hereditary colorectal neoplasms  Genetic
testing  Gastroenterology  Risk assessment  Health
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Introduction
Worldwide, colorectal cancer (CRC) is among the five
most common forms of cancer for both men and women.
Although CRC is a common cause of cancer deaths, mor-
tality can be reduced if cases are detected and treated early
[WHO fact sheet http://www.who.int/mediacentre/fact
sheets/fs297/en/(November 2014)]. Approximately 10–30 %
of colorectal cancers have a familial or hereditary nature
[1, 2]. Health professionals (e.g. gastroenterologists and sur-
geons) function as gatekeepers, identifying patients at risk and
providing them with initial information on heredity. Recog-
nition of hereditary CRC syndromes (e.g. Lynch syndrome,
familial adenomatous polyposis) is important to help iden-
tify high-risk patients and provide them with appropriate
surveillance and surgical options. Recently published practice
guidelines for genetic testing and management of hereditary
gastrointestinal cancer syndromes stressed the importance of a
standard minimal cancer family history assessment in gas-
trointestinal (GI) practice [3]. Despite the relatively high
frequency of familial and hereditary CRC syndromes and the
proven benefit of screening, referral for genetic counselling
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appears to be suboptimal leading to under-diagnosis of
hereditary CRC [4]. Furthermore, referral is often patient-
initiated leading to under-representation of patients with a
lower education level, as they are less able to discuss their
need for genetic counselling [5].
At the Gastro-Intestinal Center Amsterdam (GIOCA)
expert centre, many patients with CRC are seen each
week. Patients are recently diagnosed with CRC or
referred to a tertiary centre for second opinion. An
explorative investigation of the referral rates at this clinic
to a clinical genetic centre for genetic counselling indi-
cated suboptimal referral and showed that medical files
had incomplete information or lacked information on
family history. Therefore, a checklist was introduced for
use by gastroenterologists and surgeons (in training) per-
forming intake consultations at this clinic to: (1) improve
the discussion on cancer in the family during the con-
sultation, and (2) provide a tool for routine use of indi-
cations for referral from this clinic to a clinical genetic
centre for genetic counselling.
However, the introduction of a checklist will only
enhance appropriate referral to genetic services if the
family history is adequately discussed with the patient.
Although it is reported that in 80 % of the consultations,
oncologists, surgeons and gastroenterologists discussed the
cancer family history [6, 7], this discussion is often sub-
optimal. Even when clinicians did address the patient’s
family history, an increased risk was only discussed in
57 % of those patients with an increased familial risk for
CRC [6]. Adequate referral may be hampered by the
clinician’s lack of knowledge; for example, Singh et al. [4]
showed that, despite the presence of clear pathological
criteria, Lynch syndrome remained under-recognised. Lack
of experience may also explain limited referral, e.g. a study
among internists showed that they experienced difficulties
in discussing heredity and genetics with their patients as
they lacked the training to do so [8]. Similarly, gastroen-
terologists and surgeons are not specifically trained in
genetics and may lack the experience and skills to ade-
quately discuss genetic issues with their patients.
This explorative study aimed to gain insight into the role
of surgeons and gastroenterologists (in training) in refer-
ring patients for genetic counselling, and to test the feasi-
bility of a supportive checklist. Specifically, this study
investigated (1) whether introduction of a checklist
increased surgeons’ and gastroenterologists’ discussion of
family history and genetic counselling in a first consulta-
tion with patients with CRC, (2) whether the quality of the
discussion of family history was sufficient to guarantee
optimal referral for genetic counselling, (3) whether the
checklist was filled in correctly, and (4) whether referrals
to a clinical genetic centre were made when appropriate.
Methods
Study design and procedures
The Medical Ethical Committee of the Academic Medical
Center gave an exemption for formal approval of the study.
Introduction of the checklist to increase discussion
of family history and genetic counselling
At the Gastro-Intestinal Centre Amsterdam (GIOCA)
expert centre all medical examinations take place on the
same day. Patients are referred to this specialized clinic for
a recently diagnosed CRC or referred as second opinion.
They have an intake consultation with either a surgeon,
surgeon in training or a gastroenterologist in training. The
residents are in the final stage of their education and are
therefore working independently, with supervision at dis-
tance. They have had only minor specific education in
oncogenetic, apart from what they have learned during
their medicine study. Subsequently, patients are discussed
in a multidisciplinary team (including gastroenterologists,
surgeons, radiotherapists, oncologists, radiologists,
pathologists and specialized nurses) and receive a treat-
ment plan (concerning surgery and (neo) adjuvant treat-
ment) the same day. The clinical geneticists are located in
the same hospital and regularly one of them is present at
the multidisciplinary meeting.
We developed a checklist which surgeons and gas-
troenterologists (in training) could use during the intake
consultation. The checklist was based on instruments
already in use in other hospitals (9) and includes criteria
for referral for genetic counselling derived from the Dutch
CBO-guidelines (http://oncoline.nl/erfelijke-darmkanker),
such as other family members with colon or endometrial
cancer, young age of the patient (\50 years) and adeno-
matous or hyperplastic polyposis (see Table 1). If one of
these criteria is present, referral for genetic counselling is
indicated. A clinical geneticist (C.A.) introduced the
checklist during a multidisciplinary meeting in which the
checklist items were explained and the checklist was
introduced as a helpful tool in daily practice. Gastroen-
terologists and surgeons were asked to use the tool to
improve referral for genetic counselling. They were not
informed that the checklist was part of the study as we
wanted to observe a realistic setting. Studies have shown
for video recordings, which is even more obtrusive than
audio recording, that recording of consultations has little
influence on the behaviour of either doctors or patients
[10, 11]. The nurses, who were informed about the pur-
pose of the study, were instructed to provide each gas-
troenterologist and surgeon (in training) with this
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checklist at each first consultation with a new patient. The
researcher (K.D.) visited the GIOCA clinic every week to
collect the questionnaires and coordinate the audio taping,
At that time she also reminded the nurses to provide the
checklist.
To investigate whether the introduction of this checklist
increases discussion on family history and the possibility of
referral for genetic counselling by surgeons and gastroen-
terologists (in training), an uncontrolled before and after
study design was used.
Table 1 Translation of checklist




Name of surgeon/gastroenterologist/ nurse practitioner: 
Telephone: 
Please  answer the questions in this checklist for all patients with colorectal carcinoma or colorectal 
polyps 
Checklist: Risk factors for hereditary or familial colorectal cancer
Yes No
Does this paent have:
- Mulple colorectal carcinomas: aged < 70 years      
- Colorectal carcinoma and a Lynch syndrome-associated tumour*    
- Colorectal carcinoma and a family member** with a Lynch syndrome-  
associated tumour* of which one < 50 years       
- Colorectal carcinoma and at least two family members** with
Lynch syndrome-associated tumour*, irrespecve of age     
- At least 10 adenomatous polyps        
- One adenomatous polyp with high-grade dysplasia < 40 years     
- At least 30 serrated polyps ***        
Is paent < 50 years and has a:
- Colorectal carcinoma?         
- Endometrium carcinoma ?        
If: at least one answer is “YES” then the paent is a candidate for genec counselling.
*Lynch syndrome-associated tumours are colorectal carcinoma, carcinomas of the endometrium, stomach, small
intesnes, pancreas, biliary, pyelum, ureter, ovarian, brains, sebaceous gland (-adenoma or -carcinoma).
**Ask for ﬁrst and second-degree family members. First-degree family members are children, brothers, sisters and
parents. Second-degree family members are grandparents, grandchildren, uncles, aunts, cousins and nieces
*** With 10 to 30 serrated polyps (hyperplasc or sessile serrated adenomas/polyps) or with histological aberrant
polyps discussion with a clinical genecist is advisable.
Paents can be referred to the department of Clinical Genecs of the AMC via telephone
number …. or e-mail …. or fax …..
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Consecutive patients with a recent diagnosis of CRC
were invited by the GIOCA nurses, after giving informed
consent, to fill in a questionnaire immediately after their
first consultation at the GIOCA outpatient clinic; one group
was invited before introduction of the checklist (the Before
group) and another group after introduction of the checklist
(the After group). The first consultation was either with a
gastroenterologist or with a surgeon (in training). The
questionnaire investigated the patients’ perception of the
degree to which family cancer history and genetic coun-
selling was discussed during the consultation.
Quality of discussing family history
After the checklist was introduced to the clinicians,
patients in the After group were asked by the researcher
(K.D.) for their written informed consent to audiotape their
consultation; the clinicians were also asked for their written
informed consent. All clinicians, mostly residents, per-
forming intake consultations at the clinic during the study
period were included, none refused. Patients and clinicians
were told that the study investigated patient-physician
communication, without stressing the use of the checklist
for discussion about cancer genetics, which was introduced
some time before. Also, it was not mentioned to the clin-
icians that we focused on the discussion of family history
and referral for genetic counselling. Neither patients nor
clinicians were aware that the questionnaire, the checklist
and the audiotapes were part of the same study.
Completeness of checklist and appropriate referral
Nurses scanned all checklists that were filled in by the
clinicians and uploaded them to the electronic medical file.
After completion of the study, the medical files of all
participating patients were reviewed.
Sample size Because of the explorative nature of the
study, a large effect size (0.80) was assumed. Based on this
effect size we calculated the needed sample size (G*Power
3.1.3) which showed that we needed 26 patients per group
(Before and After). However, when taking into account a
non-response of 30 % we aimed to invite 40 patients before
introduction of the checklist and another 40 patients after
introduction of the checklist, to fill in the questionnaire.
Study sample
All five gastroenterologists in training, one surgeon, and
three surgeons in training that were working at the clinic
during the time of the study agreed to participate. None
refused. Consecutive eligible patients with CRC referred to
the GIOCA for a first consultation were invited to
participate. Inclusion criteria were: a diagnosis of CRC,
age C 18 years, and adequate command of the Dutch
language. Patients who were already known with heredi-
tary cancer in the family were excluded.
Measures
Patient questionnaire
The questionnaire asked for: (1) patients’ age and gender;
(2) patients’ perception regarding whether cancer in the
family was discussed during the consultation (yes/no) and
who initiated this discussion (doctor/patient/don’t know);
(3) when patients did discuss cancer in the family, they
were asked what was discussed; whether the doctor asked:
(a) who in the family has (had) cancer? (yes/no), (b) about
cancer in first-degree family members (yes/no/don’t
remember), (c) about cancer in second-degree family
members (yes/no, don’t remember), (d) about the type of
cancer of family members? (yes/no), and (e) about the age
of the family members at the time of a cancer diagnosis?
(yes/no); (4) finally, if relevant, patients were asked if the
clinicians discussed (a) the possibility of a hereditary
cancer syndrome (yes/no/don’t know) and (b) related
genetic topics. The questionnaire was self-developed by a
medical psychologist (K.D.) and clinical geneticist (C.A.)
specifically for this study, based on daily practice, and pilot
tested among several patients visiting the GIOCA clinic
prior to the start of the study.
Audiotapes
The audiotaped consultations were transcribed verbatim.
To determine whether cancer genetic topics were ade-
quately discussed to guarantee optimal referral for genetic
counselling, K.D and C.A. formulated criteria (see
Table 2) based on the Dutch CBO-guidelines (http://onco
line.nl/erfelijke-darmkanker). This led to three categories
which we visualised as a ‘traffic light’): (1) red; cancer in
the family was not discussed, (2) orange; cancer in the
family was inadequately discussed, (3) green, cancer in the
family was adequately discussed to determine whether an
indication for referral to genetic counselling was present.
In addition, we explored the type of questions used by
clinicians during consultations in which cancer in the
family was inadequately discussed, and coded them with
labels such as ‘vague’, ‘multi-interpretable’, and ‘steering’.
Medical records
Medical records were reviewed for the following infor-
mation: (1) if the checklist: (a) was present (yes/no),
(b) was complete (yes/no), (c) revealed an indication for
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referral for genetic counselling based on the available
information (yes/no), and (2) if the patient was referred for
genetic counselling (yes/no). A checklist was coded as
incomplete if one or more of the boxes remained
unchecked, or when a question mark was placed next to an
uncrossed box.
Data analysis
Descriptive statistics were used to describe the study
sample. Independent t-tests and Chi square tests were used
to compare age and gender between the Before and After
group. If differences in age and gender were present,
logistic regression analysis was used to evaluate whether
age and/or gender were significantly related to the outcome
variables, i.e. discussing a family history of cancer during
the consultation, initiative for discussion, and what was
discussed (who, first-degree, second-degree, type and age)
at the univariate level. If age and/or gender appeared to
have no significant influence, results of the Pearson’s Chi
square test and Fisher’s exact test are reported to describe
differences between the Before and After group. Other-
wise, the results of the logistic regression analyses con-
trolling for age and/or gender are presented.
All analyses were performed using IBM SPSS version
20.0. A p value of 0.05 (two-sided) was considered
significant.
Using the criteria described above, all transcripts of the
audiotapes were reviewed by K.D. and double coded by
C.A. Differences between codings were discussed and, in
case the coders were uncertain about the coding, a third
coder, E.D., was asked to also code the transcripts.
Results
Study sample
Table 3 presents the characteristics of the study sample.
Most patients were seen by two of the five gastroenterol-
ogists in training, or by the surgeon.
A flow diagram of the inclusion is show in Fig. 1. In the
Before group, 54 patients were eligible of which 45 (83 %)
participated. One questionnaire was excluded because of
many missing values, resulting in a final sample of 44
patients.
In the After group, 46 eligible patients were approached
for the questionnaire and 37 (80 %) participated. In the
After group, 38 patients were approached for audiotaping
of their consultations, of whom 37 consented (response
97 %); however, because one recording failed, the final
sample consisted of 36 audiotapes. Also, because patients
were invited by the researcher about audiotaping before the
consultation, and by the nurse regarding the questionnaire
after the consultation, some patients did not participate in
both audiotaping and the questionnaire (Table 3). In total
52 patients were included in the After group (16 ques-
tionnaire only, 15 audiotapes only and 21 both question-
naire and audiotape).
Between the Before and After group there were no
significant differences for gender, but patients in the Before
Table 2 Coding scheme used in this study









Yes Discussed are: number of family members
with cancer, type of cancer and age. A clear
distinction was made between first and
second-degree relatives
Do you have other family members with
cancer? What type of cancer did they get?
How old were they when they got cancer?
No Family in the cancer is clearly discussed and
there are no other cancers in this family
Do you have other family members with
cancer? (and then ask probing questions, such
as: Also, no second-degree family members?)
Orange Inadequately
discussed
Yes The discussion does not fulfil the criteria
mentioned above. e.g. the patient gives
information about 1 person, and the
specialist does not ask about the rest of the
family
‘‘How old is your mother?’’ (Instead of asking
how old the family member was at the time
of diagnosis)
No The discussion is multi-interpretable,
therefore it is unclear whether other family
members have cancer
‘‘Are there people in your family with cancer
or polyps or that kind of thing?’’
Red Not discussed n/a The clinician does not ask about cancer in the
family
n/a
Gatekeeper role of gastroenterologists and surgeons in recognising and discussing familial… 235
123
Table 3 Characteristics of the population sample
Variable Before (n = 44) After (n = 52) p value
Mean Range Mean Range
Age in years 67.9 43–91 62.6 39–86 0.02
N % N %
Gender 0.68
Male 27 61 34 65
Female 17 39 18 35
Intake consultation with… 0.74
Gastroenterologist 26 59 29 56
Surgeon 18 41 23 44
Participation*
Questionnaire 44 16 31
Audiotape n/a 15 29
Both audiotape and questionnaire n/a 21 40
* Because patients were invited by the researcher for permission to audiotape before the consultation, and by the nurse to complete the



































Due to the separate inclusion procedures for the quesonnaires
and audiotaping the ﬁnal sample aer introducon of the




audiotapes (n=15) Audiotapes (n=21)
Fig. 1 Flow diagram of the inclusion
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group were significantly older (p = 0.02). However, as age
had no significant influence on any outcome variable, we
did not correct for age in the analyses and report the results
of the Pearson’s Chi square and Fisher’s exact tests.
Did introduction of the checklist increase discussion
of family history and genetic counselling?
There were no significant differences between the Before
and After group regarding patients’ perception of dis-
cussing cancer in the family, but some trends were
observed (Table 4). More patients in the After group
reported discussing (1) cancer in the family (before 77 %
vs after 89 %; p = 0.16), (2) second-degree family mem-
bers (before 53 % vs after 75 %, p = 0.15), (3) type of
cancer (before 75 % vs after 91 %; p = 0.24), and (4) age
at which family members had cancer (before 55 % vs after
76 %; p = 0.15). Table 5 shows which topics were dis-
cussed with patients who were told by the clinician that
there was a suspicion of a hereditary form of cancer.
Was the quality of discussing family history sufficient
to guarantee optimal referral for genetic counselling?
In 28 % (n = 10) of the audiotaped consultations family
history was adequately enough discussed to determine
whether an indication for referral to genetic counselling
was present, in 58 % (n = 21) the discussion was consid-
ered inadequate, and in 14 % (n = 5) of the consultations it
was not discussed at all. Below, we present examples of
adequate and inadequate discussions.
An example of an adequate discussion:
Table 4 Discussion of cancer genetic topics
Topics discussed according to the patients Before (n = 44) After (n = 36) V2 (df) p value
N % N %
1. Family members with cancer 34 77 33 89 2.00 (1) 0.16
Patient has no family members with cancer 12 27 11 30
Patient has family members with cancer 22 50 22 60
2. Who have had cancer 20 95 21 100 n/a 1.00
3. First-degree family members 19 95 21 96 n/a 1.00
4. Second-degree family members 10 53 15 75 2.12 (1) 0.15
5. Type of cancer of family members 15 75 19 91 n/a 0.24
6. Age at which family members got cancer 11 55 16 76 2.05 (1) 0.15
7. Clinician took the initiative to discuss family history of cancer 29 91 26 84 n/a 0.47
For question 2, 3, 5 and 7 the p value from the Fisher’s exact test (2-sided) is reported; the remaining p values are from the Pearson’s Chi square
test
Table 5 Topics discussed in case of possible hereditary cancer
According to patients Before After V2 (df) p value
N % N %
The consultation showed that the cancer is possibly hereditary 5 24 7 33 0.47 (1) 0.50
Topics discussed
Why the doctor thinks there is a possibility of hereditary cancer 2 40 4 57
Which types of genetic tests are available 2 40 4 57
How genetic testing works 1 20 0 0
The consequences of genetic testing for the patient self 1 20 0 0
The consequences of genetic testing for the patient’s family 1 20 2 29
Something else* 0 0 2 29
None of these topics were discussed with me 2 40 1 14
* Advice given to sister, and explanation of statistically high risks
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Gastroenterologist (G) with female patient
• G: … and I also wondered if, in your family, are there
any, do you have brothers, sisters or parents or
grandmother with bowel problems?
• Patient: My brother had.. that started with esopha-
geal cancer and lung cancer.
• G: Oh.
• P: And then he got a stoma and the connection was
made from out of the stomach
• G: Yes, yes, he had surgery
• P: in the end that broke down. So he passed away.
And my mother had Parkinson’s disease. And my
father…[not understandable].
• G: Alright, but no colorectal cancer or, and also no
grandfathers and grandmothers, cousins as far as
you are aware?
• P: … not the intestines.
• G: … not the intestines. Or other? So only your
brother had esophageal cancer, but overall not many
others.
• P:… he smoked a terrible amount and also drank a
terrible amount.
• G: But as far as you are aware it is not known
whether there are many other tumors, breast
cancer, cervical cancer in your family.
• P:… my sister has rheumatism, that is also serious,
but well, that has nothing to do with it.
An example of an inadequate discussion:
Surgeon (S) has a consultation with a male patient.
• S: What I was wondering? Are there any family
members with bowel polyps or colorectal cancer?
• P: No.
• S: No. No, nobody?
• P: No, no. On my mother’s side they are strong.
• S: All right.
• Surgeon is typing.
Another example of an inadequate discussion:
Gastroenterologist (G) with male patient
• G: … and are there other family members with it,
brothers, sisters or eh.. parents?
• Wife: No colorectal cancer, but eh, lung cancer and
breast cancer, Hodgkin’s…
• P: Bladder cancer.
• Wife: Bladder cancer. Large family. He comes from
a large family.
• G: Yes. But no colorectal cancer?
• Wife: No, not as far as we know. No, nobody has it.
• G: All right.
In addition, more in-depth explorative analysis of the
audiotapes showed that, in consultations in which cancer
in the family was inadequately discussed, the clinicians
asked vague, unfinished, very general and steering ques-
tions, or more than one question at the same time. Vague
questions are unclear questions which could be interpreted
in several ways by a patient. For example, ‘and do you
have brothers and sisters of your own? All?’. Unfinished
questions are questions that need to be filled in by
patients themselves and can therefore be interpreted in
several ways. For example, ‘No, and do you have sisters
with….’. Very general questions are questions that do not
direct the patient in any way to become more specific
about their family history. For example, ‘What we want
to know in advance, thinking it might be cancer, is that
we always want to know the family history.’ Steering
questions are questions which steer the answer of the
patient in a specific direction. For example, ‘and fur-
thermore, what I would like to know, in your family there
is nobody with colorectal disease?’. Sometimes clinicians
asked several questions at once, As a result, it remains
unclear to which part of the question a yes/no answer of
the patient refers. For example, ‘but there are not many or
other tumours, breast cancer, uterine cancer in your
family?’’
Was the checklist filled in correctly?
Of the 52 medical files of the After group that were
reviewed, a checklist was present in 27 (53 %) of them
(one file could not be reviewed due to a missing patient
number). Of the 27 available checklists, 5 (19 %) were
incomplete (e.g. question marks on the checklist, or several
boxes not crossed); the remaining 22 (81 %) were com-
pleted correctly.
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Were referrals made when appropriate?
For 6 (29 %) patients the checklist indicated that a referral
for genetic counselling would be appropriate. According to
their medical files, 5 (83 %) of those patients were referred
for genetic counselling and 1 patient (17 %) was not.
Discussion
This explorative study investigated the role of surgeons and
gastroenterologists in training in recognising familial risk
for CRC. Also examined was the feasibility of using a
checklist to enhance discussion of family history of cancer
and referral for genetic counselling.
Contrary to our expectations, the checklist did not
increase the discussion of cancer in the family during the
first consultation, as reported by the patients. Importantly,
cancer in the family was already discussed in most (77 %)
of the intake consultations before introduction of the
checklist. This relatively high frequency of discussion of
cancer in the family (e.g. who have had cancer, type of
cancer) suggests a ceiling effect, i.e. little room is left for
improvement. Interestingly, two other studies (performed
at the same time as ours) demonstrated that oncologists,
surgeons and gastroenterologists discussed a cancer family
history in a comparable percentage (80 %) of consultations
[6, 7]. However, those studies did not explore the detailed
content of the discussion of family history during an actual
consultation.
When examining details of the discussion on family
history of cancer, our study shows that the quality of the
discussion is inadequate in most consultations (72 %).
Importantly, all but one of the clinicians were residents
who, because still in training, may have a harder time
recognizing potential at risk patients and discussing family
history. However, as they are supervised at distance,
investigating family history is an important task as they
have to inform their supervisor adequately about the cancer
family history of the patient. As a consequence, patients
with an indication for genetic counselling could well have
been missed. Thus, specific training of communication
skills might be warranted. Education of healthcare pro-
fessionals should not only enable understanding and utili-
sation, but also effective communication about genetics
[12, 13], i.e. investigating the family history in a structured
way using open-ended non-steering questions and
prompting. In that way, gastroenterologists and surgeons
(in training) may better contribute to a more adequate
referral of patients to genetic counselling.
In this study, only in about half of the consultations was
the checklist present in the medical file and about one-fifth
of the checklists were incomplete; this suggests that the
clinicians had difficulty using them, or had missed relevant
data. The brief introduction given by a clinical geneticist for
this study might not have been sufficient for these clini-
cians. Furthermore, although the checklist was placed on
the desk of the health professional by the nurse before the
consultation, there was no obligation to use it. Also, because
health professionals may lack knowledge on genetics [8, 14,
15], clinicians in the present study may have found it dif-
ficult to use the checklist properly. In line with our findings,
a recent randomised controlled trial among gastroenterol-
ogists and surgeons aimed at improving recognition and
referral for familial CRC risk (through a website, patient-
targeted brochures, and clinician-targeted education and
pocket referral cards), showed that improving knowledge
did not improve referral rates [9]. Therefore there seems to
be potential to improve genetic cancer history taking of
residents by adding a mandatory curriculum that addresses
proper genetic history evaluation.
Lack of time might also play a role in busy clinics,
where diagnosis and treatment planning take place on the
same day. Guidelines recommend that familial risk of CRC
and preventive measures be assessed on diagnosing CRC
(http://oncoline.nl/erfelijke-darmkanker). However, health
professionals might not consider this to be the right time to
discuss cancer in the family. For 13 patients we explored
this further by audiotaping all their consultations during
that day. We observed that if this topic was not addressed
during the intake consultation, then it was not raised in any
of the subsequent consultations on that day either.
Why should we pursue family history at all now DNA
technology is readily available at increasingly lower cost
[16]? Potentially, all tumours could be tested for Lynch
syndrome and the polyposis syndromes. However, if no
mutation is detected, surveillance by colonoscopy may still
be warranted because the family history might be sugges-
tive for familial CRC. Furthermore, another hereditary
condition may be present, such as serrated polyposis,
Cowden or Peutz-Jeghers syndrome, and also for these
conditions family history may be helpful in revealing these
conditions.
It should be noted that this was an explorative study with
an uncontrolled before and after design. Therefore, our
results might be explained by differences between the
groups before and after introduction of the checklist (as is
the case for age), and by time effects. Furthermore, as
mentioned before there could have been a ceiling effect,
because cancer in the family was already discussed in most
intake consultations. Also, the checklist was only briefly
introduced by the clinical geneticist during a multidisci-
plinary meeting and this might not have been sufficient
instruction for the, residents participating in this study. A
strength of the study is the use of a mixed method design,
which gives a better impression of what actually happens
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during a consultation from multiple perspectives. Further-
more, to our knowledge this is the first study to investigate
a detailed discussion of the family history in clinical
practice.
To conclude, this explorative study shows that gas-
troenterologists and surgeons, of which most were in
training, have difficulty in fulfilling their gatekeeper role of
recognising patients at familial risk for CRC. Although
they often discuss cancer in the family during the initial
consultation, their investigation is not always sufficient to
reveal all indications for referral for genetic counselling.
Furthermore, this study shows that the introduction of a
checklist might not necessarily solve the problem of sub-
optimal referral. Interventions other than a checklist (e.g.
training in communication skills) might be needed to
improve exploration of cancer in the patient’s family and
improve the referral rates.
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